These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14322582)

  • 1. KINETICS OF THE BACTERICIDAL ACTION OF NORMAL SERUM ON GRAM-NEGATIVE BACTERIA.
    DAVIS SD; WEDGWOOD RJ
    J Immunol; 1965 Jul; 95():75-9. PubMed ID: 14322582
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES RELATING TO THE SERUM RESISTANCE OF CERTAIN GRAM-NEGATIVE BACTERIA.
    OSAWA E; MUSCHEL LH
    J Exp Med; 1964 Jan; 119(1):41-51. PubMed ID: 14115824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LYSOZYME LYSIS OF GRAM-NEGATIVE BACTERIA WITHOUT PRODUCTION OF SPHEROPLASTS.
    VOSS JG
    J Gen Microbiol; 1964 May; 35():313-7. PubMed ID: 14179677
    [No Abstract]   [Full Text] [Related]  

  • 4. COMPARISON OF BACTERICIDAL AND HEMOLYTIC SERUM SYSTEMS. I. INHIBITORY EFFECTS OF NORMAL HUMAN SERUM FRACTIONS.
    SCHNEIDER LE; MIYAMA A; BRAUN W; PLESCIA OJ; BJOERKLUND B
    Proc Soc Exp Biol Med; 1964 May; 116():80-2. PubMed ID: 14200140
    [No Abstract]   [Full Text] [Related]  

  • 5. CHARACTERIZATION OF THE BACTERICIDAL ACTION OF PRECOLOSTRAL PIGLET AND CALF SERA AGAINST GRAM NEGATIVE ENTERIC BACTERIA IN ROUGH PHASE.
    TACHIBANA DK
    Folia Microbiol (Praha); 1965 May; 10():145-55. PubMed ID: 14344772
    [No Abstract]   [Full Text] [Related]  

  • 6. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
    Veringa E; Box A; Rozenberg-Arska M; Verhoef J
    Drugs Exp Clin Res; 1988; 14(1):1-8. PubMed ID: 3292179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential metabolic expressions of the lethal process in human serum-treated Escherichia coli: role of lysozyme.
    Martinez RJ; Carroll SF
    Infect Immun; 1980 Jun; 28(3):735-45. PubMed ID: 6156906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [IMPORTANCE OF INDUCTION BY THYMINE DEFICIENCY ON THE VIABILITY OF THYMINE-REQUIRING BACTERIA].
    SICARD N
    C R Hebd Seances Acad Sci; 1964 Sep; 259():2040-2. PubMed ID: 14208708
    [No Abstract]   [Full Text] [Related]  

  • 9. THE PATHOGENESIS OF STRANGULATION OBSTRUCTION. EFFECT OF HEMOGLOBIN ON BACTERICIDAL CAPACITY OF HUMAN LEUKOCYTES.
    BALCH HH; KELLEY D
    J Surg Res; 1965 Jun; 5():262-4. PubMed ID: 14296967
    [No Abstract]   [Full Text] [Related]  

  • 10. [NONSPECIFIC SERO-BACTERIOLYSIS AND ACQUIRED RESISTANCE TO ANTIBIOTICS IN E. COLI].
    HAZEGHI K; GINDRAT JJ
    Pathol Microbiol (Basel); 1965; 28():122-9. PubMed ID: 14299855
    [No Abstract]   [Full Text] [Related]  

  • 11. THE INFLUENCE OF BACTERIOCINS ON RESISTANCE TO INFECTION BY GRAM-NEGATIVE BACTERIA. I. THE EFFECT OF COLICIN ON BACTERICIDAL POWER OF BLOOD.
    BRAUDE AI; SIEMIENSKI JS
    J Clin Invest; 1965 May; 44(5):849-59. PubMed ID: 14276142
    [No Abstract]   [Full Text] [Related]  

  • 12. LYTIC ACTION OF CHLORPROMAZINE HYDROCHLORIDE ON ESCHERICHIA COLI G. CELLS.
    AGARWAL RP; GUHA A
    Br J Pharmacol Chemother; 1965 Apr; 24(2):466-9. PubMed ID: 14320861
    [No Abstract]   [Full Text] [Related]  

  • 13. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilized N-alkylated polyethylenimine avidly kills bacteria by rupturing cell membranes with no resistance developed.
    Milović NM; Wang J; Lewis K; Klibanov AM
    Biotechnol Bioeng; 2005 Jun; 90(6):715-22. PubMed ID: 15803464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.
    Ma Q; Guo Z; Gao C; Zhu R; Wang S; Yu L; Qin W; Xia X; Gu J; Yan G; Lei L
    Antonie Van Leeuwenhoek; 2017 Mar; 110(3):347-355. PubMed ID: 27943012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [INVESTIGATIONS CONCERNING THE ACTION OF 4 TETRACYCLINES ON 31 STRAINS OF GRAM-NEGATIVE BACTERIA].
    BREITFELLNER G; NEUHOLD R
    Chemotherapia (Basel); 1964; 64():41-52. PubMed ID: 14178044
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of the extracellular bacteriolytic enzymes of Lysobacter sp. on gram-negative bacteria].
    Begunova EA; Stepnaia OA; Tsfasman IM; Kulaev IS
    Mikrobiologiia; 2004; 73(3):320-5. PubMed ID: 15315224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinetic study of the bacteriolytic and bactericidal action of human serum.
    Glynn AA; Milne CM
    Immunology; 1967 Jun; 12(6):639-53. PubMed ID: 5338688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.
    Yan G; Liu J; Ma Q; Zhu R; Guo Z; Gao C; Wang S; Yu L; Gu J; Hu D; Han W; Du R; Yang J; Lei L
    Antonie Van Leeuwenhoek; 2017 Dec; 110(12):1627-1635. PubMed ID: 28730370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.